Search

Your search keyword '"CoMSIA"' showing total 47 results

Search Constraints

Start Over You searched for: Descriptor "CoMSIA" Remove constraint Descriptor: "CoMSIA" Journal european journal of medicinal chemistry Remove constraint Journal: european journal of medicinal chemistry
47 results on '"CoMSIA"'

Search Results

1. Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies.

2. In silico studies and fluorescence binding assays of potential anti-prion compounds reveal an important binding site for prion inhibition from PrPC to PrPSc.

3. Design, synthesis and 3D-QSAR studies of new diphenylamine containing 1,2,4-triazoles as potential antitubercular agents.

4. CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.

5. Synthesis and 3D-QSAR study of 1,4-dihydropyridine derivatives as MDR cancer reverters.

6. Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents.

7. Design, synthesis and 3D-QSAR analysis of novel 2-hydrazinyl-4-morpholinothieno[3,2-d]pyrimidine derivatives as potential antitumor agents

8. Homology modeling in tandem with 3D-QSAR analyses: A computational approach to depict the agonist binding site of the human CB2 receptor

9. Docking and 3D-QSAR (quantitative structure activity relationship) studies of flavones, the potent inhibitors of p-glycoprotein targeting the nucleotide binding domain

10. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) of some benzimidazole derivatives with trichomonicidal activity

11. Design of semisynthetic analogues and 3D-QSAR study of eunicellin-based diterpenoids as prostate cancer migration and invasion inhibitors

12. 3D-QSAR analysis of human immunodeficiency virus entry-1 inhibitors by CoMFA and CoMSIA

13. Three-dimensional quantitative structure–activity relationship CoMSIA/CoMFA and LeapFrog studies on novel series of bicyclo [4.1.0] heptanes derivatives as melanin-concentrating hormone receptor R1 antagonists

14. Exploring benzcyclo derivatives as potent aromatase inhibitors using ligand-based modeling studies

15. 3D-QSAR studies of latrunculin-based actin polymerization inhibitors using CoMFA and CoMSIA approaches

16. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase

17. Molecular modeling studies of Rho kinase inhibitors using molecular docking and 3D-QSAR analysis

18. CoMFA and CoMSIA studies on HIV-1 attachment inhibitors

19. A comparison of different electrostatic potentials on prediction accuracy in CoMFA and CoMSIA studies

20. 3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models

21. Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP

22. 3D QSAR studies on ketoamides of human cathepsin K inhibitors based on two different alignment methods

23. 3D QSAR study of the toxicity of trichothecene mycotoxins

24. Docking-based 3D-QSAR study of HIV-1 integrase inhibitors

25. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors

26. Novel Biginelli dihydropyrimidines with potential anticancer activity: A parallel synthesis and CoMSIA study

27. Application of 3D QSAR CoMFA/CoMSIA and in silico docking studies on novel renin inhibitors against cardiovascular diseases

28. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors

29. 2D- and 3D-QSAR studies on 54 anti-tumor Rubiaceae-type cyclopeptides

30. Development of CoMFA and CoMSIA models of affinity and selectivity for indole ligands of cannabinoid CB1 and CB2 receptors

31. Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: Docking-based CoMFA and CoMSIA analyses

32. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods

33. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach

34. 3D and quantum QSAR of non-benzodiazepine compounds

35. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides

36. 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA

37. Insights into the structural requirements of farnesyltransferase inhibitors as potential anti-tumor agents based on 3D-QSAR CoMFA and CoMSIA models

38. Structure-based 3D-QSAR studies on heteroarylpiperazine derivatives as 5-HT3 receptor antagonists

39. Three-dimensional quantitative structure–activity relationship studies on diverse structural classes of HIV-1 integrase inhibitors using CoMFA and CoMSIA

40. Understanding the antitumor activity of novel tricyclicpiperazinyl derivatives as farnesyltransferase inhibitors using CoMFA and CoMSIA

41. 3D QSAR for GSK-3β inhibition by indirubin analogues

42. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA

43. 3D-QSAR studies of indole derivatives as phosphodiesterase IV inhibitors

44. Hydrazones of 1,2-benzisothiazole hydrazides: synthesis, antimicrobial activity and QSAR investigations

45. Design, synthesis and 3D-QSAR analysis of novel thiopyranopyrimidine derivatives as potential antitumor agents inhibiting A549 and Hela cancer cells.

46. CoMFA and CoMSIA analysis of ACE-inhibitory, antimicrobial and bitter-tasting peptides.

47. Design, synthesis and evaluation of analogs of initiation factor 4E (eIF4E) cap-binding antagonist Bn7-GMP.

Catalog

Books, media, physical & digital resources